MESOESTETIC, S.L. – Trademark Portfolio

Entity Type: 16

MESOESTETIC, S.L. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 4 are pending. Notable registered marks include AGE ELEMENT and MELAPHENONE.

Av. de la Tecnología, 25

E-08840 VILADECANS (Barcelona)

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MESOESTETIC, S.L.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (7 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MESOESTETIC, S.L. have?

MESOESTETIC, S.L. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 pending, 1 abandoned.

What trademark classes does MESOESTETIC, S.L. file in?

MESOESTETIC, S.L. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are MESOESTETIC, S.L.'s most well-known trademarks?

MESOESTETIC, S.L.'s registered trademark portfolio includes well-known marks such as AGE ELEMENT and MELAPHENONE. These are among 2 currently registered trademarks in the portfolio.

What is MESOESTETIC, S.L.'s trademark registration success rate?

MESOESTETIC, S.L. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.